Published in Nat Genet on December 01, 1999
Comparative genomics of the eukaryotes. Science (2000) 26.62
Learning cell biology as a team: a project-based approach to upper-division cell biology. Cell Biol Educ (2002) 8.68
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev (2002) 6.44
Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev (2008) 6.18
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature (2010) 5.26
The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2002) 4.25
Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci U S A (2000) 3.82
Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci U S A (2000) 3.43
Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell (2001) 3.41
Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci U S A (2004) 2.89
Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity. PLoS Biol (2006) 2.70
Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc Natl Acad Sci U S A (2004) 2.56
The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev (2008) 2.39
Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci U S A (2003) 2.32
Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin. Dis Model Mech (2008) 2.29
Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci (2010) 2.29
Mechanism of prion loss after Hsp104 inactivation in yeast. Mol Cell Biol (2001) 2.27
Heat shock proteins as emerging therapeutic targets. Br J Pharmacol (2005) 2.25
Heat shock protein 70 (hsp70) as an emerging drug target. J Med Chem (2010) 2.21
Amino acid runs in eukaryotic proteomes and disease associations. Proc Natl Acad Sci U S A (2002) 2.17
Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J Cell Biol (2000) 2.11
A survey of human disease gene counterparts in the Drosophila genome. J Cell Biol (2000) 2.09
PGC-1α rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med (2012) 2.07
Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest (2005) 2.06
Caloric restriction and intermittent fasting: two potential diets for successful brain aging. Ageing Res Rev (2006) 1.94
Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket. Curr Med Chem (2008) 1.84
A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila. Proc Natl Acad Sci U S A (2003) 1.84
Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Genes Dev (2008) 1.81
Autophagy promotes synapse development in Drosophila. J Cell Biol (2009) 1.79
Cellular strategies of protein quality control. Cold Spring Harb Perspect Biol (2011) 1.74
Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nat Rev Drug Discov (2011) 1.71
Genetic modifiers of tauopathy in Drosophila. Genetics (2003) 1.70
Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones. J Biol Chem (2008) 1.69
Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells. Cell (2008) 1.69
Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet (2007) 1.66
Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease. J Clin Invest (2011) 1.66
Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity. Proc Natl Acad Sci U S A (2002) 1.65
Altered transcription in yeast expressing expanded polyglutamine. Proc Natl Acad Sci U S A (2001) 1.58
blue cheese mutations define a novel, conserved gene involved in progressive neural degeneration. J Neurosci (2003) 1.57
Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc Natl Acad Sci U S A (2001) 1.53
Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies. Proc Natl Acad Sci U S A (2005) 1.52
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci U S A (2001) 1.51
Pharmacological targeting of the Hsp70 chaperone. Curr Top Med Chem (2009) 1.51
Chaperoning brain degeneration. Proc Natl Acad Sci U S A (2002) 1.51
Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage. Exp Biol Med (Maywood) (2010) 1.50
Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc Natl Acad Sci U S A (2002) 1.48
Protein homeostasis in models of aging and age-related conformational disease. Adv Exp Med Biol (2010) 1.48
Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease. PLoS Biol (2010) 1.47
Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors. Proc Natl Acad Sci U S A (2004) 1.47
Neuronal circuitry regulates the response of Caenorhabditis elegans to misfolded proteins. Proc Natl Acad Sci U S A (2011) 1.46
An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J (2006) 1.45
Hsp70 and its molecular role in nervous system diseases. Biochem Res Int (2011) 1.44
CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins. Hum Mol Genet (2008) 1.43
Suppression of protein aggregation by chaperone modification of high molecular weight complexes. Brain (2012) 1.42
Toward understanding Machado-Joseph disease. Prog Neurobiol (2011) 1.42
Chaperone networks: tipping the balance in protein folding diseases. Neurobiol Dis (2010) 1.42
An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta -fibrils. Proc Natl Acad Sci U S A (2001) 1.38
TOR-mediated autophagy regulates cell death in Drosophila neurodegenerative disease. J Cell Biol (2009) 1.38
Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm. Neuron (2008) 1.38
Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease. J Clin Invest (2008) 1.38
Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc Natl Acad Sci U S A (2002) 1.36
Temperature-sensitive paralytic mutants are enriched for those causing neurodegeneration in Drosophila. Genetics (2002) 1.34
Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein. Genes Dev (2003) 1.33
A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics (2010) 1.32
Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation. Biochem Biophys Res Commun (2006) 1.32
In vivo generation of neurotoxic prion protein: role for hsp70 in accumulation of misfolded isoforms. PLoS Genet (2009) 1.29
Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation. J Biol Chem (2010) 1.29
Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease. Proc Natl Acad Sci U S A (2000) 1.28
Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool. J Biol Chem (2010) 1.28
Intranuclear degradation of polyglutamine aggregates by the ubiquitin-proteasome system. J Biol Chem (2009) 1.26
Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment. Proc Natl Acad Sci U S A (2002) 1.24
Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease. J Neurosci (2009) 1.24
A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J Biol Chem (2008) 1.23
Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity. Proc Natl Acad Sci U S A (2012) 1.23
A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1. EMBO J (2006) 1.18
Amyloid deposits: protection against toxic protein species? Cell Cycle (2009) 1.18
Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease. J Cell Biol (2012) 1.18
Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet (2011) 1.18
Polyglutamine disease and neuronal cell death. Proc Natl Acad Sci U S A (2000) 1.14
Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90). Hum Mol Genet (2010) 1.13
A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr Opin Struct Biol (2010) 1.13
Drosophila models of neurodegenerative disease. NeuroRx (2005) 1.12
Interactions between Hsp70 and the hydrophobic core of alpha-synuclein inhibit fibril assembly. Biochemistry (2008) 1.11
Huntington's Disease. Cold Spring Harb Perspect Biol (2011) 1.11
Machado-Joseph disease/spinocerebellar ataxia type 3. Handb Clin Neurol (2012) 1.09
Bax-like protein Drob-1 protects neurons from expanded polyglutamine-induced toxicity in Drosophila. EMBO J (2005) 1.08
Disruption of protein quality control in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 1.07
Chaperone-mediated hierarchical control in targeting misfolded proteins to aggresomes. Mol Biol Cell (2011) 1.06
Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport. Biochemistry (2011) 1.05
Molecular chaperones as rational drug targets for Parkinson's disease therapeutics. CNS Neurol Disord Drug Targets (2010) 1.04
Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias. Neurochem Res (2011) 1.04
Loss of Hsp70 in Drosophila is pleiotropic, with effects on thermotolerance, recovery from heat shock and neurodegeneration. Genetics (2005) 1.04
Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. Cerebellum (2014) 1.03
Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology. Am J Pathol (2004) 1.03
Alzheimer's disease: insights from Drosophila melanogaster models. Trends Biochem Sci (2009) 1.03
NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy. Hum Mol Genet (2011) 1.02
Amyloid in neurodegenerative diseases: friend or foe? Semin Cell Dev Biol (2011) 1.02
Targeting protein aggregation for the treatment of degenerative diseases. Nat Rev Drug Discov (2015) 1.02
Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis. Neurobiol Dis (2010) 1.02
Hsp70 and Hsp40 functionally interact with soluble mutant huntingtin oligomers in a classic ATP-dependent reaction cycle. J Biol Chem (2010) 1.01
Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell (1998) 4.07
Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol (1998) 2.37
CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet (2000) 2.18
Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum Mol Genet (2000) 2.17
The Drosophila eyes absent gene directs ectopic eye formation in a pathway conserved between flies and vertebrates. Development (1997) 2.06
Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet (1999) 1.95
Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. J Neurosci (1999) 1.93
Housing quality and mental health. J Consult Clin Psychol (2000) 1.77
Modeling human neurodegenerative diseases in Drosophila: on a wing and a prayer. Trends Genet (2000) 1.41
Transvection at the eyes absent gene of Drosophila. Genetics (1994) 1.38
Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology (2011) 1.32
Allele-specific RNA interference for neurological disease. Gene Ther (2006) 1.32
Cloning and characterization of two vertebrate homologs of the Drosophila eyes absent gene. Genome Res (1997) 1.25
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nat Genet (2000) 1.25
Do human neutrophils make hydroxyl radical? Determination of free radicals generated by human neutrophils activated with a soluble or particulate stimulus using electron paramagnetic resonance spectrometry. J Biol Chem (1986) 1.24
TGF-beta receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung. Eur Respir J (2008) 1.22
Fibroblasts transfected with Torpedo acetylcholine receptor beta-, gamma-, and delta-subunit cDNAs express functional receptors when infected with a retroviral alpha recombinant. J Cell Biol (1989) 1.20
Uranium stabilization of c28: a tetravalent fullerene. Science (1992) 1.20
Trinucleotide repeat expansion in neurological disease. Ann Neurol (1994) 1.20
Regulation of ciliary motility by membrane potential in Paramecium: a role for cyclic AMP. Cell Motil Cytoskeleton (1986) 1.19
Polyglutamine disease and neuronal cell death. Proc Natl Acad Sci U S A (2000) 1.14
Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system. Neurobiol Dis (1997) 1.13
Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers. Oncogene (2012) 1.13
The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease. J Biol Chem (2001) 1.08
Genetic reconstitution of functional acetylcholine receptor channels in mouse fibroblasts. Science (1987) 1.06
Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis. Dev Biol (2001) 1.06
Molecular genetic analysis of Drosophila eyes absent mutants reveals an eye enhancer element. Genetics (2000) 1.05
Induction of apoptosis by Elk-1 and deltaElk-1 proteins. Oncogene (1998) 1.05
Gingivae contain neural-crest- and mesoderm-derived mesenchymal stem cells. J Dent Res (2013) 1.04
The mechanism of TGF-β signaling during palate development. Oral Dis (2011) 1.04
Separation and determination of strychnine and brucine in Strychnos nux-vomica L. and its preparation by capillary zone electrophoresis. Biomed Chromatogr (2000) 1.03
Molecular analysis of Drosophila eyes absent mutants reveals features of the conserved Eya domain. Genetics (2000) 1.03
Parenchymal cell proliferation and mechanisms for maintenance of granular duct and acinar cell populations in adult male mouse submandibular gland. Anat Rec (1993) 1.02
Stimulated human neutrophils limit iron-catalyzed hydroxyl radical formation as detected by spin-trapping techniques. J Biol Chem (1986) 1.00
Theory of networked minority games based on strategy pattern dynamics. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 1.00
Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics. Pharmacogenomics J (2012) 0.98
Molecular and cellular regulatory mechanisms of tongue myogenesis. J Dent Res (2012) 0.97
A cell culture model for androgen effects in motor neurons. J Neurochem (1998) 0.96
Role of extracellular iron in the action of the quinone antibiotic streptonigrin: mechanisms of killing and resistance of Neisseria gonorrhoeae. Antimicrob Agents Chemother (1987) 0.95
Cost-effectiveness of prenatal screening for thalassaemia in Hong Kong. Prenat Diagn (2004) 0.94
Effects of human serum on the growth and metabolism of Neisseria gonorrhoeae: an alternative view of serum. Infect Immun (1985) 0.94
Endothelial cell-specific expression of tumor necrosis factor-alpha from the KDR or E-selectin promoters following retroviral delivery. Hum Gene Ther (1997) 0.93
Drosophila models of human neurodegenerative disease. Cell Death Differ (2000) 0.93
Dual functions of the Drosophila eyes absent gene in the eye and embryo. Mech Dev (1998) 0.92
Randomised trial comparing an interactive multimedia decision aid with a leaflet and a video to give information about prenatal screening for Down syndrome. Prenat Diagn (2004) 0.91
The Drosophila embargoed gene is required for larval progression and encodes the functional homolog of schizosaccharomyces Crm1. Genetics (2000) 0.90
Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix. Hum Mol Genet (1999) 0.90
Association of gonadotropin receptor precursors with the protein folding chaperone calnexin. Endocrinology (1998) 0.89
Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients. J Med Virol (2010) 0.89
[Identification and characterization of differentially expressed ESTs of Gossypium barbadense infected by Verticillium dahliae with suppression subtractive hybridization]. Mol Biol (Mosk) (2005) 0.89
Three-dimensional reconstruction of adult female mouse submandibular gland secretory structures. Anat Rec (1990) 0.89
Determination of synthetic drugs used to adulterate botanical dietary supplements using QTRAP LC-MS/MS. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2009) 0.88
Epithelial fibroblast growth factor receptor 1 regulates enamel formation. J Dent Res (2008) 0.88
Functional modulation of the ATP-sensitive potassium channel by extracellular signal-regulated kinase-mediated phosphorylation. Neuroscience (2008) 0.88
Double heterozygous mutations of MITF and PAX3 result in Waardenburg syndrome with increased penetrance in pigmentary defects. Clin Genet (2012) 0.88
Effect of prolonged hypoxia on food consumption, respiration, growth and reproduction in marine scavenging gastropod Nassarius festivus. Mar Pollut Bull (2008) 0.87
Regulation of cell growth by oxidized LDL. Free Radic Biol Med (2000) 0.86
Comparison of inter- and intraobserver agreement between three types of fetal volume measurement technique (XI VOCAL, VOCAL and multiplanar). Ultrasound Obstet Gynecol (2009) 0.86
Functional analysis of an eye enhancer of the Drosophila eyes absent gene: differential regulation by eye specification genes. Dev Biol (2000) 0.85
Fetal biometry by an inexperienced operator using two- and three-dimensional ultrasound. Ultrasound Obstet Gynecol (2010) 0.85
Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKKε. Eur Rev Med Pharmacol Sci (2015) 0.84
Comparison of inter- and intraobserver agreement and reliability between three different types of placental volume measurement technique (XI VOCAL, VOCAL and multiplanar) and validity in the in-vitro setting. Ultrasound Obstet Gynecol (2010) 0.83
Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis. Mech Dev (2000) 0.83
Tgf-beta-mediated FasL-Fas-Caspase pathway is crucial during palatogenesis. J Dent Res (2011) 0.83
Giant fibrous tumours of the pleura with mucus secretion. Niger J Clin Pract (2013) 0.83
A patient with commotio cordis successfully resuscitated by bystander cardiopulmonary resuscitation and automated external defibrillator. Hong Kong Med J (2010) 0.82
Gene expression, signal transduction and tissue-specific biomineralization during mammalian tooth development. Crit Rev Eukaryot Gene Expr (1992) 0.81
Vascular endothelial growth factor transgenic mice exhibit reduced male fertility and placental rejection. Mol Hum Reprod (2001) 0.81
Glial cell line-derived neurotrophic factor promotes survival and induces differentiation through the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathway respectively in PC12 cells. Neuroscience (2001) 0.80
Antagonistic effects of Smad2 versus Smad7 are sensitive to their expression level during tooth development. J Biol Chem (2001) 0.80
Amyloid-beta induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity. Neuromolecular Med (2009) 0.79
DNA synthesis and development strategies with possible consequences on sexual dimorphism in adult mouse submandibular glands. Crit Rev Oral Biol Med (1993) 0.79
Appearance of acinar-cell-specific mucin in prenatal mouse submandibular glands. Differentiation (1989) 0.78
[Expression of genes aroG and pheA in phenylalanine biosynthesis]. Wei Sheng Wu Xue Bao (1999) 0.78
The ubiquitin ligase F-box/G-domain protein 1 promotes the degradation of the disease-linked protein torsinA through the ubiquitin-proteasome pathway and macroautophagy. Neuroscience (2012) 0.78
Axillary lymph node scarring and the association with tumour response following neoadjuvant chemoendocrine therapy for breast cancer. Breast (2001) 0.78
Nerve growth factor (NGF) supports tooth morphogenesis in mouse first branchial arch explants. Dev Dyn (1999) 0.77
The new interfacial ubiquity of surface-enhanced Raman spectroscopy. Anal Chem (2000) 0.77
Prenatal exposure to nitrofen induces Fryns phenotype in mice. Ann Plast Surg (2001) 0.77
The effects on maternal anxiety of two-dimensional versus two- plus three-/four-dimensional ultrasound in pregnancies at risk of fetal abnormalities: A randomized study. Ultrasound Obstet Gynecol (2006) 0.77
BRCA1 splice variants BRCA1a and BRCA1b associate with CBP co-activator. Oncol Rep (1998) 0.76
Effect of 17beta-estradiol exposure on vasorelaxation induced by K(+) channel openers and Ca(2+) channel blockers. Pharmacology (2002) 0.76
Serious eye injury caused by rotating wire brushes. Br J Ophthalmol (1995) 0.75
Current controversies in breast cancer surgery. Clin Oncol (R Coll Radiol) (2012) 0.75
Impact of nonpenetrating clips on intimal hyperplasia of vascular anastomoses. Cardiovasc Surg (2001) 0.75
Dual aetiologies for hyperinsulinaemic hypoglycaemia in one patient. Hong Kong Med J (2007) 0.75
Diagnosis and treatment of spinal fractures combined with paraplegia and diaphragm injury. Chin J Traumatol (2001) 0.75
Morphometric analysis of coated pits and vesicles in the proximal and distal caput epididymidis. Biol Reprod (1985) 0.75
Carbon nanotube thermal interface material for high-brightness light-emitting-diode cooling. Nanotechnology (2008) 0.75
Three-dimensional movement analysis of lateral pterygoid electromyographic activity during mastication in the rat. Arch Oral Biol (1988) 0.75
Gate voltage dependent characteristics of p-n diodes and bipolar transistors based on multiwall CN(x)/carbon nanotube intramolecular junctions. Nanotechnology (2007) 0.75
Immunocytochemical localization of alpha-lactalbumin in the male reproductive tract. Biol Reprod (1984) 0.75